Home » Newsletters » BioWorld Asia

BioWorld Asia

April 4, 2001

View Archived Issues

Micromet Raises EUR40M In Fourth Financing Round

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

Transgene Decides To Refocus, Concentrate On Cancer Programs

Meristem Partners With Goodwin To Gain Foothold In U.S. Market

Alchemia Raises A$15.2M To Expand Research, U.S. Operation

Canada Invests C$21M For Stem Cell Research Initiative

EMEA Sets Out Plans Covering Biotechnology For Next 2 Years

Hybrigenics Launches Map On Protein HIV Interactions

Other News To Note

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

New Group Formed To Assess Drug Competitiveness Issues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...